Seattle, WA, March 14, 2016: PATH today announced the formation of the PATH Center for Vaccine Innovation and Access to accelerate the development and introduction of lifesaving vaccines for the most vulnerable children and communities around the world. The new center will build on PATH’s nearly 20 years of success in developing and delivering vaccines to improve global health. It brings together PATH’s vaccine projects into a single team working across every stage of the long and complex process of vaccine research, development, and introduction. Read more.
Toward a world where no one dies for want of a vaccine
In a blog, Dr. David Kaslow, Vice President of Product Development and head of the Center for Vaccine Innovation and Access at PATH, notes that the new center will "ensure that we have the right talent and resources along the entire vaccine life cycle." Read more.